Cargando…

“Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost”

PURPOSE: To describe a previously unreported case of reversible myopic shift with corresponding changes in corneal contour in a patient treated with netarsudil/latanoprost. OBSERVATIONS: A 72-year-old male with history of primary open angle glaucoma, prior cataract surgery, and remote radial keratot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, David, Meier, Edward J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978266/ https://www.ncbi.nlm.nih.gov/pubmed/35387385 http://dx.doi.org/10.1016/j.ajoc.2022.101501

Ejemplares similares

Netarsudil-associated reticular corneal epithelial edema
por: Tran, Jennifer A., et al.
Publicado: (2022)

Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
por: Wisely, C. Ellis, et al.
Publicado: (2020)

Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis
por: Lee, Jong-Wook, et al.
Publicado: (2022)

Two pediatric cases of reticular corneal epithelial edema associated with netarsudil
por: Guzman Aparicio, Maria A., et al.
Publicado: (2022)

Reticular corneal epithelial edema with topical netarsudil
por: Parmar, Dipali P., et al.
Publicado: (2023)

Netarsudil-associated epithelial keratopathy
por: Ramakrishnan, Meera S., et al.
Publicado: (2020)

Netarsudil-Induced Corneal Flattening in a Child with Secondary Open-Angle Glaucoma
por: Ganesh, Durga, et al.
Publicado: (2022)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
por: Wang, Tao, et al.
Publicado: (2022)

Case report: The use of netarsudil to improve corneal edema after laser peripheral iridotomy and Descemet's membrane endothelial keratoplasty
por: Chen, Sabrina L., et al.
Publicado: (2021)

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
por: Asrani, Sanjay, et al.
Publicado: (2020)

Anterior segment optical coherence tomography features of netarsudil-associated reticular corneal edema
por: Khalili, Ashley, et al.
Publicado: (2022)

Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit
por: Chen, Wensheng, et al.
Publicado: (2014)

Immunologic Corneal Graft Rejection after Administration of Topical Latanoprost: a Report of Two Patients
por: Nouri-Mahdavi, Kouros, et al.
Publicado: (2011)

Correction: Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit
Publicado: (2014)

Effects of the Glaucoma Drugs Latanoprost and Brimonidine on Corneal Temperature
por: Konieczka, Katarzyna, et al.
Publicado: (2019)

Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal Dystrophy
por: Lindstrom, Richard L., et al.
Publicado: (2022)

Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials
por: Luo, Nachuan, et al.
Publicado: (2022)

The role of latanoprost in an inflammatory bowel disease flare
por: Paul, Sonali, et al.
Publicado: (2014)

Severe Cutaneous Reaction to Latanoprost Eye Drops
por: Yip, Ivan Yeu Ming, et al.
Publicado: (2018)

A Case Report Illustrating the Postoperative Course of Descemetorhexis without Endothelial Keratoplasty with Topical Netarsudil Therapy
por: Ploysangam, Pimpiroon, et al.
Publicado: (2019)

Latanoprost-associated cystoid macular edema in a patient with phakic eyes
por: Lin, Wei-Che, et al.
Publicado: (2022)

A Patient with Corneal Epithelial Disorder That Developed after Administration of a Latanoprost Generic, but Not a Brand-Name Drug, Eye Drop
por: Takada, Yukihisa, et al.
Publicado: (2012)

Uveitis-induced Refractory Ocular Hypotony Managed with High-dose Latanoprost
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Prostaglandin-associated periorbitopathy in latanoprost users
por: Nakakura, Shunsuke, et al.
Publicado: (2014)

Latanoprost in the treatment of glaucoma
por: Alm, Albert
Publicado: (2014)

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost
por: Imasawa, Mitsuhiro, et al.
Publicado: (2016)

Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms
por: Ren, Ruiyi, et al.
Publicado: (2016)

Extended Latanoprost Release from Commercial Contact Lenses: In Vitro Studies Using Corneal Models
por: Mohammadi, Saman, et al.
Publicado: (2014)

Comparison of In Vitro Corneal Permeation and In Vivo Ocular Bioavailability in Rabbits of Three Marketed Latanoprost Formulations
por: Chauchat, Laure, et al.
Publicado: (2023)

Latanoprost Induced Iris Pigment Epithelial and Ciliary Body Cyst Formation in Hypermetropic Eyes
por: Mohite, Abhijit Anand, et al.
Publicado: (2017)

Bilateral Serous Detachment Associated with Latanoprost/Timolol Fixed Combination Use: A Report of One Phakic Case
por: Ayhan Tuzcu, Esra, et al.
Publicado: (2012)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
por: Radcliffe, Nathan, et al.
Publicado: (2020)

Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect
por: Samuel, Sandy, et al.
Publicado: (2022)

Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature
por: Makri, Olga E., et al.
Publicado: (2017)

The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
por: Kazemi, Arash, et al.
Publicado: (2018)

Influence of Latanoprost on Retinal Microcirculation in Glaucoma
por: Kremmer, S, et al.
Publicado: (2014)

Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost
por: Nutterova, Elena, et al.
Publicado: (2022)

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
por: Lin, Cheng-Wen, et al.
Publicado: (2018)

Dose-dependent effects of netarsudil, a Rho-kinase inhibitor, on the distal outflow tract
por: Chen, Si, et al.
Publicado: (2020)

Effectiveness of Netarsudil as an Additional Therapy for Glaucoma in Patients Already on Maximally Tolerated Medical Therapy
por: Villegas, Natacha C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jsatjlk3vg3b2eah9u2iamjp97